Issue navigation
Volume 110, Issue 12, December 2018
Editorials
Survivorship Care Plan: We’ve Got the Tool—It’s Time to Fix the Process
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1285–1286, https://doi.org/10.1093/jnci/djy077
Can Less Be More for Individuals With Low-Risk Breast Cancer?
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1287–1289, https://doi.org/10.1093/jnci/djy129
P16 as a Prognostic Biomarker for Nonoropharyngeal Squamous Cell Cancers: Avatar or Mirage?
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1290–1291, https://doi.org/10.1093/jnci/djy103
Commentary
Cancer Survivorship and Employment: Intersection of Oral Agents, Changing Workforce Dynamics, and Employers’ Perspectives
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1292–1299, https://doi.org/10.1093/jnci/djy172
Long-Term Survivorship Care After Cancer Treatment - Summary of a 2017 National Cancer Policy Forum Workshop
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1300–1310, https://doi.org/10.1093/jnci/djy176
Reviews
Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1311–1327, https://doi.org/10.1093/jnci/djy177
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1328–1341, https://doi.org/10.1093/jnci/djy171
Articles
Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1342–1351, https://doi.org/10.1093/jnci/djy070
Randomized Trial of the Impact of Empowering Childhood Cancer Survivors With Survivorship Care Plans
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1352–1359, https://doi.org/10.1093/jnci/djy057
Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1360–1369, https://doi.org/10.1093/jnci/djy059
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1370–1379, https://doi.org/10.1093/jnci/djy128
A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1380–1385, https://doi.org/10.1093/jnci/djy058
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1386–1392, https://doi.org/10.1093/jnci/djy060
Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1393–1399, https://doi.org/10.1093/jnci/djy072
Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1400–1408, https://doi.org/10.1093/jnci/djy063
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1409–1417, https://doi.org/10.1093/jnci/djy067
Brief Communication
Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1418–1421, https://doi.org/10.1093/jnci/djy114
Correspondence
RE: Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1422–1423, https://doi.org/10.1093/jnci/djy068
Response to H. Nabi et al.
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 12, December 2018, Pages 1424–1425, https://doi.org/10.1093/jnci/djy069
